Search

Your search keyword '"BCG therapy"' showing total 340 results

Search Constraints

Start Over You searched for: Descriptor "BCG therapy" Remove constraint Descriptor: "BCG therapy"
340 results on '"BCG therapy"'

Search Results

51. Ruptured aortic aneurysm due to Mycobacterium bovis BCG with a delayed bacteriological diagnosis due to false negative result of the MPB 64 immunochromatographic assay.

52. Dendritic cells in blood and urine samples from bladder cancer patients undergoing BCG immunotherapy

53. Ultrasonographic findings in a patient with reactive arthritis induced by intravesical BCG therapy for bladder cancer.

54. An unusual case of a tuberculous granuloma of the liver presenting thirteen years after intravesical BCG – therapy for bladder cancer

56. Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update

57. EVALUATION OF RISK FACTORS AFFECTING RECURRENCE AND PROGRESSION AFTER BCG THERAPY IN NON-MUSCLE INVASIVE BLADDER CANCER

58. Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer

59. Findings from Central University Punjab Yields New Data on Bacillus Calmette-Guerin Vaccines (Bacillus Calmette Gaurine Vaccine Ameliorates the Neurotoxicity of Quinolinic Acid In Rats Via the Modulation of Antioxidant, Inflammatory and...).

60. Findings from University of Massachusetts Update Knowledge of Bacillus Calmette-Guerin Vaccines (Host Genetic Background Is a Barrier To Broadly Effective Vaccine-mediated Protection Against Tuberculosis).

61. Data on Bacillus Calmette-Guerin Vaccines Discussed by Researchers at Sun Yat Sen Zhongshan University (Intravesical Pseudomonas Aeruginosa Mannose-sensitive Hemagglutinin Vaccine Triggers a Tumor-preventing Immune Environment In an Orthotopic...).

62. Red Cross War Memorial Children's Hospital Researchers Describe Recent Advances in Bacillus Calmette-Guerin Vaccines (A rare mutation causing autosomal dominant STAT1 deficiency in a South African multiplex kindred with disseminated BCG...).

63. Research Study Findings from Erzincan Binali Yildirim University Update Understanding of Bacillus Calmette-Guerin Vaccines (Diagnosis of Latent Tuberculosis Infection in Hemodialysis Patients: TST versus T-SPOT.TB).

65. Researchers from University of Southern Denmark Discuss Findings in Influenza A Virus (Immunogenicity of Bacillus Calmette-Guerin in pigs: potential as a translational model of non-specific effects of BCG).

66. Recent Findings in Bacillus Calmette-Guerin Vaccines Described by Researchers from University of California Davis School of Medicine (Effects of Bacillus Calmette-Guerin on immunometabolism, microbiome and liver diseases).

67. Findings from Charles University of Prague Provides New Data on Bacillus Calmette-Guerin Vaccines (Manifestations of Cutaneous Mycobacterial Infections In Patients With Inborn Errors of Il-12/il-23-ifn? Immunity).

68. Data on Bacillus Calmette-Guerin Vaccines Detailed by Researchers at Columbia University (Neo-adjuvant Immunotherapies: Bladder Cancer As a Platform for Drug Development Targeting Mucosal Immunity).

69. PD51-06 PROGRESSION AFTER BCG THERAPY: REFINING PATIENT SELECTION FOR NEOADJUVANT CHEMOTHERAPY BEFORE RADICAL CYSTECTOMY

70. PD09-09 IMPLICATIONS OF GUIDELINE-BASED, RISK-STRATIFIED RESTAGING TRANSURETHRAL RESECTION OF HG TA UROTHELIAL CARCINOMA ON BCG THERAPY OUTCOMES

71. PD42-03 HIGH LEVELS OF BASELINE IGG1, IGG3, AND IFN-G MAY BE ASSOCIATED WITH RESISTANCE TO BCG THERAPY FOR TREATMENT OF NMIBC

72. New Bacillus Calmette-Guerin Vaccines Data Have Been Reported by Researchers at McMaster University (Subcutaneous Bcg Vaccination Protects Against Streptococcal Pneumonia Via Regulating Innate Immune Responses In the Lung).

73. New Bacillus Calmette-Guerin Vaccines Research Reported from Statens Serum Institute (A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG).

74. Patent Issued for Vaccine (USPTO 11628211).

75. New Bacillus Calmette-Guerin Vaccines Study Findings Recently Were Reported by Researchers at University of Padjadjaran (Successful Treatment of Anogenital Warts With Single Dose Bacillus Calmette Guerin Vaccine Without Prior Sensitization In...).

76. Reports from Radboud University Nijmegen Describe Recent Advances in COVID-19 (The Impact of Circadian Rhythm On Bacillus Calmette-guerin Vaccination Effects On Sars-cov-2 Infections).

77. Data on Experimental Autoimmune Encephalomyelitis Detailed by Researchers at University of Sassari (Bacillus Calmette-guerin Tokyo-172 Vaccine Provides Age-related Neuroprotection In Actively Induced and Spontaneous Experimental Autoimmune...).

78. Findings in the Area of Liposomes Reported from Anhui University of Science and Technology (Long-term Immunogenicity and In Vitro Prophylactic Protective Efficacy of M. Tuberculosis Fusion Protein Dr2 Combined With Liposomal Adjuvant Dimq As a...).

79. Recent Studies from Wuhan University Add New Data to Bacillus Calmette-Guerin Vaccines (Bacillus Calmette-guerin-induced Interleukin-10 Inhibits S100a8/a9 Production and Hinders Development of T Helper Type 1 Memory In Mice).

80. New Tuberculosis Study Findings Reported from National Center for Infectious and Parasitic Diseases (Genome Sequences of Bcg Pasteur Atcc 35734 and Its Derivative, the Vaccine Candidate Bcg Delta Bcg1419c).

81. New Bacillus Calmette-Guerin Vaccines Research from Universidade Federal de Sao Paulo Discussed [Implications of the non-specific effect induced by Bacillus Calmette-Guerin (BCG) vaccine on vaccine recommendations].

82. Unusual evolution of reactive arthritis induced by BCG therapy

83. Disseminated Mycobacterium Sepsis with Bone Marrow, Liver, and Lung Involvement Following Intravesical Bacillus Calmette-Guerin (BCG) Therapy

84. Hepatic Injury without Granulomatous Formation Associated with Intravesical Bacillus Calmette-Guérin Therapy

85. Effects and Complications of Intravesical Instillation of Bacillus Calmette-Guerin Therapy

86. Long-term results of adjuvant intravesical chemotherapy with titanium glycerosolvate aquacomplex in patients with high risk nonmuscle-invasive bladder cancer

87. The role of molecular genetic alterations in sensitivity of the adjuvant intravesical therapy for non-muscle invasive bladder cancer

88. Перспективы применения метода внутрипузырной гипертермической химиотерапии в лечении пациентов с мышечно-неинвазивным раком мочевого пузыря

89. A possible protective role for Bacillus Calmette-Guérin therapy in urinary bladder cancer in the era of COVID-19: a brief report

90. Oncological outcomes of high-grade T1 non-muscle-invasive bladder cancer treatment in octogenarians

91. Intravesical Salvage Therapy After BCG/Regular Chemo

92. СРАВНИТЕЛЬНАЯ ОЦЕНКА КАЧЕСТВА ЖИЗНИ ПАЦИЕНТОВ МЫШЕЧНОНЕИНВАЗИВНЫМ РАКОМ МОЧЕВОГО ПУЗЫРЯ, ПОЛУЧАЮЩИХ АДЪЮВАНТУЮ ВНУТРИПУЗЫРНУЮ ТЕРАПИЮ

93. Findings from Charles University of Prague Update Knowledge of Bacillus Calmette-Guerin Vaccines (Manifestations of Cutaneous Mycobacterial Infections In Patients With Inborn Errors of Il-12/il-23-ifn Gamma Immunity).

94. Boston Children's Hospital Researchers Add New Study Findings to Research in Bacillus Calmette-Guerin Vaccines (A MAPS Vaccine Induces Multipronged Systemic and Tissue-Resident Cellular Responses and Protects Mice against Mycobacterium ...).

95. Studies Conducted at Nihon University School of Medicine on Bacillus Calmette-Guerin Vaccines Recently Published (The Induction of Antigen 85B-Specific CD8+ T Cells by Recombinant BCG Protects against Mycobacterial Infection in Mice).

96. About three cases of Mycobacterium bovis bone and joint infections after BCG therapy

97. Comparative prostate MRI before and after chronic granulomatous prostatitis following intravesical bacillus Calmette–Guérin therapy

98. Genetyczne i immunologiczne uwarunkowania odpowiedzi na dopęcherzową terapię BCG w raku urotelialnym pęcherza moczowego nienaciekającym błony mięśniowej.

99. Role of tumor microenvironment in the efficacy of BCG therapy

100. PD03-07 A MULTI-INSTITUTIONAL EVALUATION OF RESCUE THERAPY WITH INTRAVESICAL GEMCITABINE AND DOCETAXOL FOR NON-MUSCLE INVASIVE BLADDER CANCER AFTER BCG FAILURE

Catalog

Books, media, physical & digital resources